BOA says AP26113 has ZERO value to Rachel McMinn's PT after the flash crash or plotted takedown.
Do you agree with BOA's MicMinn? AP26113, a lifesaving lung cancer drug, has ZERO value?
Is she a professional analyst? Her unprofessional behavior and bashing attitude at last Friday's Ariad CC were well noticed and criticized by biotech_researcher. He believes she is unprofessional and pathetic.
Do the rating and price target by such a pathetic BOA analyst make any sense?
Yes, they are the best contra indications in biotech_researcher's words.